The clinical results achieved with arsenic trioxide (As2O3) in acute promyelocytic leukemia (APL) have prompted investigations to determine the mechanisms mediating its activity. This ‘bedside to b...
No takes yet. Share an insight, caveat, or question.
Dennis Carney (2008) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: